Kardiochirurgia i Torakochirurgia Polska

Full text

2/2026 vol. 23
Review paper

Contemporary overview of current percutaneous mechanical circulatory support devices for advanced heart failure: a narrative review

Trasha Shetty 1
,
Anshuman Darbari 1

  1. CTVS Department, AIIMS, Rishikesh, India

Kardiochirurgia i Torakochirurgia Polska 2026; 23 (2): 127-136

DOI: https://doi.org/10.5114/kitp.2026.163278
Data publikacji online: 2026/07/21
Article file
Contemporary overview.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Abnousi F, Yong CM, Fearon W, Banerjee D. The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock. Curr Cardiol Rep 2015; 17: 40.
  2. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T; Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS); American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirma tion of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol 2015; 65: e7-e26.
  3. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011; 57: 688-696.
  4. Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardio genic shock-Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003; 51: 312-317.
  5. Burzotta F, Russo G, Previ L, Bruno P, Aurigemma C, Trani C. Impella: pumps overview and access site management. Minerva Cardioangiol 2018; 66: 606-611.
  6. Cheng, A, Swartz MF, Massey HT. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J 2013; 59: 533-536.
  7. Frisoli TM, Guerrero M, O’Neill WW. Mechanical circulatory support with Impella to facilitate percutaneous coronary intervention for post-TAVI bilateral coronary obstruction. Catheter Cardiovasc Interv 2016; 88: E34-E37.
  8. Raess DH, Weber DM. Impella 2.5. J Cardiovasc Trans Res 2009; 2: 168-172.
  9. Panagides V, Vase H, Shah SP, Basir MB, Mancini J, Kamran H, Batra S, Laine M, Eiskjær H, Christensen S, Karami M, Paganelli F, Henriques JPS, Bonello L. Impella CP implantation during cardiopulmonary resuscitation for cardiac arrest: a multicenter experience. J Clin Med 2021; 10: 339.
  10. Ziemba EA, John R. Mechanical circulatory support for bridge to decision: which device and when to decide. J Card Surg 2010; 25: 425-433.
  11. Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouviere P, Albat B, Colson P. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Crit Care 2015; 19: 363.
  12. Valdes CA, Bilgili A, Reddy A, Sharaf O, Jimenez-Contreras F, Stinson G, Ahmed M, Vilaro J, Parker AM, Az Al-Ani M, Demos D, Aranda J, Bleiweis M, Beaver TM, Jeng EI. Impella 5.5: a systematic review of the current literature. Innovations 2024; 19: 380-389.
  13. Sultan I, Kilic A, Kilic A. Short-term circulatory and right ventricle support in cardiogenic shock: extracorporeal membrane oxygenation, Tandem Heart, CentriMag, and Impella. Heart Fail Clin 2018; 14: 579-583.
  14. Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O’Neill W. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT Study of the Impella RP Device. J Heart Lung Transplant 2015; 34: 1549-1560.
  15. Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: “TandemHeart” for high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65: 346-352.
  16. Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock. Circ Cardiovasc Interv 2017; 10: e004337.
  17. Burkhoff D, Cohen H, Brunckhorst C. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandenHeart percutaneous ventricular assist device versus conventional therapy with intraaortic baloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469.1-469.e8.
  18. Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. Outcomes with the Tandem Protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J 2018; 64: 570-572.
  19. John KJ, Nabzdyk CGS, Chweich H, Mishra AK, Lal A. ProtekDuo percutaneous ventricular support system-physiology and clinical applications. Ann Transl Med 2024; 12: 14.
  20. Brewer JM, Maybauer MO. The ProtekDuo cannula: a comprehensive review of efficacy and clinical applications in right ventricular failure. J Clin Med 2024; 13: 4077.
  21. Van Mieghem NM, Daemen J, den Uil C, Dur O, Joziasse L, Maugenest AM, Fitzgerald K, Parker C, Muller P, van Geuns RJ. Design and principle of the HeartMate PHP (percutaneous heart pump). Euro Interv 2018; 13: 1662-1666.
  22. Introducing heartmate phpTM 2023 https://sante.ro/wp-content/uploads/2016/04/PHP-Brochure_English_ 2015. pdf Accessed 5 July 2023.
  23. Puzzle Medical Devices Inc. 2023 https://www. puzzlemed.com/ Accessed 5 July 2023.
  24. Georges G, Trudeau F, Doucet-Martineau J, Rochon M, Potvin J, Ebner A, Généreux P. First-in-human experience with the ModulHeart device for mechanical circulatory support and renal perfusion. J Soc Cardiovasc Angiography Interv 2022; 1: 100449.
  25. Yamazaki K, Okamoto E, Yamamoto K, Mitamura Y, Tanaka T, Yozu R. The valvopump, an axial blood pump implanted at the heart valve position: concept and initial results. Artif Org 1992; 16: 297-299.
  26. Keeble T, Smith E, Ferrari M, Hullin R, Fredrik S, Reitan O, Rothman M. TCT-378 Interim analysis of the Reitan Catheter Pump (RCP) heart failure efficacy study: RCP improves cardiovascular and renal function in acute decompensated heart failure (ADHF). JACC 2012; 60 (17 Suppl): B108.
  27. Retain O, Öhlin H, Peterzén B, Granfeldt H, Steen S, Emanuelsson H. Initial tests with a new cardiac assist device. ASAIO J 1999; 45: 317-321.
  28. Retain O, Steen S, Öhlin H. Hemodynamic effects of a new percutaneous circulatory support device in a left ventricular failure model. ASAIO J 2003; 49: 731-736.
  29. Miller LW, Ebner A, Leonhardt H, Richardson MJ. First in human experience with the second heart assist device. ASAIO J 2020; 66: 29.
  30. Second heart assist HP 2023 https://secondheartinc.com/ Accessed 5 July 2023.
  31. Annamalai SK, Esposito ML, Reyelt LA, Natov P, Jorde LE, Karas RH, Kapur NK. Abdominal positioning of the next generation intra-aortic fluid entrainment pump(Aortix) improves cardiac output in a swine model of heart failure. Circ Heart Fail 2018; 11: e005115.
  32. Shabari FR, George J, Cuchiara MP, Langsner RJ, Heuring JJ, Cohn WE, Hert-zog BA, Delgado R. Improved hemodynamics with a novel miniaturized intra-aortic axial flow pump in a pocine model of acute left ventricular dysfunction. ASAIO J 2013; 59: 240-245.
  33. Wang R, Pei Z, Shen L, Song S, Ge J. TCT-580 CFD-based performance prediction and comprehensive evaluation of a newly development percutaneous ventricular assist device. J Am Coll Cardiol 2024; 84 (18 Suppl): B213.
  34. Toda K, Loforte A, Tchantchaleishvili V. Report on the 30th Annual Meeting of the International Society for Mechanical Circulatory Support (ISMCS). Artif Organs 2025; 2025: 1-11.
  35. Henriques JP, Remmelink M, Baan J, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97: 990-992.
  36. Sjauw KD, Remmelink M, Baan J, Lam K, Engstrom AE, van der Schaaf RJ, Vis MM, Koch KT, van Straalen JP, Tijssen JG, de Mol BA, de Winter RJ, Piek JJ, Henriques JP. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol 2008; 51: 1044-1046.
  37. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschin- ger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588.
  38. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrom T, Hassager C, Machado FP, Peddrazini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JP. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device: the Europella registry. J Am Coll Cardiol 2009; 54: 2430-2434.
  39. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O’Neill W. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry. Catheter Cardiovasc Interv 2012; 80: 717-725.
  40. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O’Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT 1 Trial): initial US experience. J Am Coll Cardiol Cardiovasc Interv 2009; 2: 91-96.
  41. PROTECT II: a prospective, multi-center, randomized controlled trial of the Impella Recover LP 2.5 system versus intra-aortic balloon pump (IABP) in patients undergoing non emergent high risk PCI. Abiomed Inc.
  42. O’Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, Pala- cios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126: 1717-1727.
  43. Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Ka- pur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O’Neill W. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015; 34: 1549-1560.
  44. Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM. Impella CP versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: the IMPRESS trial. J Am Coll Cardiol 2017; 69: 278-287.
  45. ClinicalTrials.gov: SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI. https://www.clinicaltrials.gov/study/NCT07010965#more-information(last accessed on December 01,2025).
  46. Wang R. SAVE-PCI: NyokAssist VAD vs. IABP in Elective High-Risk PCI Small-Bore: Late-breaking Clinical Science, TCT Conference 2025, San Francisco.
Copyright: © 2026 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications